NDC Active Ingredient Deferasirox

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0078-0468	Exjade	Deferasirox	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0469	Exjade	Deferasirox	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0470	Exjade	Deferasirox	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0654	Jadenu	Deferasirox	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0655	Jadenu	Deferasirox	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0656	Jadenu	Deferasirox	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0713	Jadenu	Deferasirox	Granule	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0720	Jadenu	Deferasirox	Granule	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0727	Jadenu	Deferasirox	Granule	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
45963-454	Deferasirox	Deferasirox	Tablet, For Suspension	Oral	Actavis Pharma, Inc.	Human Prescription Drug
45963-455	Deferasirox	Deferasirox	Tablet, For Suspension	Oral	Actavis Pharma, Inc.	Human Prescription Drug
45963-456	Deferasirox	Deferasirox	Tablet, For Suspension	Oral	Actavis Pharma, Inc.	Human Prescription Drug

There are 12 NDC products with the active ingredient DEFERASIROX.